Multiple Sclerosis Clinical Trial
Teriflunomide Male Transmission Study
Summary
It is known that teriflunomide, a treatment for relapsing forms of multiple sclerosis, can be found in low concentrations in semen. Because the drug has been associated with teratogenicity in laboratory animals, the question is raised as to whether the drug can be detected in female partners of sexually active males who are taking the drug to treat their multiple sclerosis.
Full Description
A total of 10 couples were enrolled in the study. Females partners had undetectable or borderline levels of teriflunomide.
Eligibility Criteria
Inclusion Criteria:
Males with relapsing forms of multiple sclerosis appropriately treated with teriflunomide 14 mg po daily;
Continuous treatment for three months with good compliance as assessed by the investigator
Age between 18 and 55
Penile-vaginal intercourse with a female partner at least twice a month with unimpeded ejaculation.
Compliance with safety assessments, e.g., regular bloodwork for complete blood count and liver function testing as recommended in the Package Insert
Able to give informed consent
Females
Regular sexual intercourse with a male partner who is actively taking teriflunomide
Age between 18 and 55
Able to give informed consent
Negative urine pregnancy test at the time of blood sampling
Reliable contraception that does not involve barrier methods
Exclusion Criteria:
Use of barrier methods of contraception
For males, contraindications to the continued use of teriflunomide
Couples that are actively trying to conceive
For males, noncompliance with teriflunomide therapy
Inability or unwilling to give consent or comply with the protocol
Pregnancy of the female sexual partner.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Derby Connecticut, 06418, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.